Ventricular Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
96
|
19
|
0.110 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Cardiac Arrhythmia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
559
|
111
|
0.100 |
None |
0.971 |
69 |
6
|
2002 |
2020 |
Atrial Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
939
|
584
|
0.100 |
None |
1.000 |
17 |
2
|
2005 |
2019 |
Heart Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
537
|
45
|
0.100 |
None |
1.000 |
11 |
|
2003 |
2019 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
3 |
3
|
2012 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2013 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Narcolepsy
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
308
|
454
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Adolescent idiopathic scoliosis
|
disease |
Musculoskeletal Diseases
|
Anatomical Abnormality
|
656
|
1178
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Rhabdomyolysis
|
phenotype |
Musculoskeletal Diseases
|
Pathologic Function
|
36
|
15
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Schizophrenia, Childhood
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
20
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
578
|
1158
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Death in infancy
|
phenotype |
|
Finding
|
146
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Sudden Cardiac Death
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
133
|
40
|
0.100 |
None |
|
0 |
|
|
|
Ventricular Arrhythmia by ECG Finding
|
phenotype |
|
Laboratory or Test Result
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Vertigo
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Sign or Symptom
|
173
|
35
|
0.100 |
None |
|
0 |
|
|
|
Right ventricular cardiomyopathy
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
15
|
4
|
0.100 |
None |
|
0 |
|
|
|
Left ventricular noncompaction cardiomyopathy
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
39
|
28
|
0.100 |
None |
|
0 |
1
|
|
|
Ventricular Arrhythmia, CTCAE 5.0
|
phenotype |
|
Finding
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Dilatation of the ventricular cavity
|
phenotype |
Cardiovascular Diseases
|
Anatomical Abnormality
|
6
|
2
|
0.100 |
None |
|
0 |
|
|
|
Electrocardiogram change
|
phenotype |
|
Finding
|
18
|
27
|
0.100 |
None |
|
0 |
2
|
|
|
Ventricular Arrhythmia, CTCAE 3.0
|
phenotype |
|
Finding
|
17
|
|
0.100 |
None |
|
0 |
|
|
|